# Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure

> **NCT03027375** · PHASE2 · UNKNOWN · sponsor: **Beijing University of Chinese Medicine** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure
- Cardiovascular Diseases

## Interventions

- **DRUG:** Qishen Granules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03027375
- **Lead sponsor:** Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-31
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-10-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03027375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03027375, "Evaluating the Safety and Efficacy of Qishen Granules Among Patients With Chronic Heart Failure". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT03027375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*